Thu, Apr 17, 2014, 1:17 PM EDT - U.S. Markets close in 2 hrs 43 mins

Recent

% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

  • cynicoptimist cynicoptimist Mar 21, 2013 10:45 AM Flag

    Basic facts

    Acknowledged, CEO has gotten ahead of himself in the past on dates and he is not an expert in FDA regulations. Original IDE was submitted in the past with deficient content and was not reviewed by Dr. Langer.

    Current IDE re-submitted end of February and addressed all the questions and was meticulously reviewed before it was submitted again based upon IR comments. Additional comments: "All transfer of data is now complete"

    We can reasonably expect the IDE approval; any other deficiency would be minimal and responded to immediately.

    Once the trials commense, we should see safety and efficacy indications in 60 days. If these are positive (expected) then the HDE gets filed and we could see revenue generation in Q4 or Q1'14 which would exceed any of the recent stock offerings and exceed the potential warrant conversions.

    Make no mistake - NVIV is VERY MUCH still not on the radar of huge #'s of investors and the appreciation of share price is potentially enormous.

    Sentiment: Strong Buy

 
NVIV
1.53-0.05(-3.16%)12:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.